Science

News
John Arnst
April 01, 2020
A small army of researchers races to build a coronavirus interactome
Led by a professor at UCSF, scientists at eight institutions in the U.S. and Europe have used a protein interaction map to identify 69 drugs that might work against SARS-CoV-2, the virus that causes COVID-19.
Read More

More in Science

Why scientists are studying if chloroquine could treat coronavirus
News

Why scientists are studying if chloroquine could treat coronavirus

March 28, 2020

Bill Sullivan takes a close look at why this old malaria drug could be promising for COVID-19.

Creating a molecular map for the plant sciences
News

Creating a molecular map for the plant sciences

March 27, 2020

Bernhard Kuster of the Technical University of Munich writes about how his lab created the first comprehensive map of the proteome of the model plant Arabidopsis thaliana.

From the journals: JBC
Journal News

From the journals: JBC

March 26, 2020

Flu-fighting fat, prevention of chemotherapy pain and activation of anti-aging enzymes. Read about recent papers on these topics and more in the Journal of Biological Chemistry.

Finding novel drug targets in tuberculosis
Journal News

Finding novel drug targets in tuberculosis

March 24, 2020

Researchers report a novel mechanism of controlling synthesis of the essential vitamin K<sub>2</sub> in the bacterial pathogen that causes tuberculosis.

Removing belly fat before it sticks to you
Journal News

Removing belly fat before it sticks to you

March 24, 2020

Researchers at the University of Cincinnati College of Medicine have found a way to produce in the laboratory a human protein that plays an important role in metabolizing and clearing excess levels of triglycerides from the bloodstream.

This disease kills half the people it infects. So why isn’t more being done?
Feature

This disease kills half the people it infects. So why isn’t more being done?

March 22, 2020

Melioidosis is a bacterial infection that quietly causes thousands of deaths each year. Meet the doctor who made it his mission to make the world take notice.

Health Observance

Parkinson's Awareness Month

It is the second-most common progressive neurodegenerative disease, occurring in 1% of people over the age of 60 and in 5% of people over 85.
Parkinson's  Awareness Month

More in Science

The bee microbiome can fight back against fungi that cause Colony Collapse Disorder
Feature

The bee microbiome can fight back against fungi that cause Colony Collapse Disorder

March 21, 2020

Biocontrol may help bees where other interventions, like chemical pesticides, have failed.

How spider venom could help relieve pain
Journal News

How spider venom could help relieve pain

March 20, 2020

Does the key to safe, effective pain treatments lie in modified tarantula venom? A recent JBC article from Janssen Research and Development offers an answer.

The best of two worlds
Journal News

The best of two worlds

March 19, 2020

Cecil Pickett’s research career spanned several decades and led to pivotal findings on oxidative stress responses and key breakthroughs in drug discovery.

'We are doers. We want to get involved.'
Life in the Lab

'We are doers. We want to get involved.'

March 18, 2020

In a department that feels almost deserted, basic scientists join the COVID-19 effort.

From the journals: MCP
Journal News

From the journals: MCP

March 18, 2020

New therapeutic targets for hyperactive mTOR, a SPEEDy way to prepare mass spec samples, and a new program to identify and validate citrullinated peptides. Read about these recent papers in the journal Molecular & Cellular Proteomics.

What makes remdesivir a promising antiviral?
News

What makes remdesivir a promising antiviral?

March 17, 2020

Clinical trials around the world are testing remdesivir, a nucleotide analog, for possible effects against the novel coronavirus. We asked some experts what makes the molecule interesting.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.